Biomonitoring Programs for State Public Health Laboratories

 

To support the development or expansion of state-based biomonitoring programs, including necessary infrastructure, that will increase the capability and capacity of state public health laboratories (1) to assess human exposure to environmental chemicals within their jurisdictions; (2) to determine which chemicals people are exposed to and the levels of those chemicals in people?s bodies; (3) to determine the prevalence of people with levels of chemicals that are above a known toxicity threshold; (4) to determine whether levels of selected chemicals are higher among minorities, children, women of childbearing age, or other potentially vulnerable groups; (5) to assess the effectiveness of state public health actions to reduce the exposure of their residents to specific chemicals of concern; (6) to compare state-generated biomonitoring data with CDC national biomonitoring data; and (7) to track trends in levels of chemicals in a state?s population or subgroups of that population over time.

Deleted 03/27/2024 (Archived.) 93.062 Centers For Disease Control and Prevention, Department of Health and Human Services B - Project Grants Not applicable. Section 317 of the Public Health Service Act, (42 U.S.C. Section 247 b), as amended. No additional information No additional information Applicants should review the individual CDC Guidance documents issued under this CFDA program for any required proof or certifications that must be submitted with the application package. Preapplication coordination is required. This program is eligible for coverage under E.O. 12372, "Intergovernmental Review of Federal Programs." An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review. Additional information can be found in the program guidance. 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Applications and required forms for this program can be obtained from Grants.gov or from the Grants Management Officer, Grants Management Branch, Procurement and Grants Office, Centers for Disease Control and Prevention. Please visit the Grants.gov Web site at www.grants.gov to find and apply for all Federal grant/cooperative agreement opportunities. After review and approval of an application, a notice of award is made in writing and issued by the Grants Management Officer, Procurement and Grants Office, CDC. Appropriate notification is also made to the public. Contact the headquarters or regional location, as appropriate for application deadlines From 60 to 90 days. Not applicable. Support is recommended for a specified project period, not to exceed 5 years, with each project period having a 12-month budget period. Proposal selection criteria can be found in the program guidance. Cooperative agreements may be made to eligible entities for the support of projects to develop or expand state-based biomonitoring programs. Funding may be used for personnel salaries (for full-time, part-time, or contractor positions), laboratory instruments and supplies, training, travel, and indirect costs. Funds may not be used for research, clinical care, furniture or office equipment, pre-award costs, or the construction of new laboratory space. In addition, the direct and primary recipient in the cooperative agreement program must perform a substantial role in carrying out project objectives and not merely serve as a conduit for an award to another party or provider who is ineligible. Performance Reports: Annual progress reports are required. In addition, grants and cooperative agreements are subject to inspection and audits by DHHS and other Federal government officials. Grantees are required to maintain grant accounting records for a minimum of 3 years after the end of a grant period. If any litigation, claim, negotiation, audit or other action involving the record has been started before the expiration of the 3-year period, the records shall be retained until completion of the action and resolution of all issues which arise from it, or until the end of the regular 3-year period, whichever is later. More detailed information regarding retention requirements is provided in 45 CFR Parts 74 and 92. Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. Support is recommended for a specified project period, not to exceed 5 years. Awards are made annually and assistance is available for a twelve month budget period. There are five budget periods within the 5-year project period. After awards are issued, funds are released in accordance with DHHS payment procedures, which may be through an Electronic Transfer System or a Monthly Cash Request System. Method of awarding/releasing assistance: Lump. None/Not specified. Robert Reynolds
4770 Buford Highway, F45
Atlanta, GA 30341 US
VIO9@cdc.gov
Phone: 770-488-0563 http://www.cdc.gov 75-0943-0-1-550 (Cooperative Agreements) FY 18$0.00; FY 19 est $25,000,000.00; FY 20 est $25,000,000.00; FY 17$0.00; FY 16$0.00; - This activity can now be found under CFDA 93.070 Not applicable/available. This program is subject to the provisions of 45 CFR Part 92 for State, local and tribal governments and 45 CFR Part 74 for institutions of higher education, hospitals, other nonprofit organizations and commercial organizations. HHS Grants Policy Statement at: http://www.hhs.gov/grantsnet/adminis/gpd/index.htm. Not applicable.